NanoString, Cancer Immunotherapy Trials Network Collaborate on Therapy Response Biomarkers | GenomeWeb

NEW YORK (GenomeWeb) – NanoString Technologies and the Cancer Immunotherapy Trials Network said after the close of the market on Tuesday they are collaborating on a multiyear research project to discover biomarkers that may be predictive of clinical outcomes for cancer immunotherapies as single agents as well as in combination. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.